INTRODUCTION: Culture is regarded as the gold standard for the detection of genital mycoplasma in clinical samples. Commercially available diagnostic kits, based on liquid broth cultures, provide interesting alternatives to conventional culture. We assessed the laboratory performances of Mycoplasma IES (IES), the Mycofast Revolution (REV) and Mycoplasma IST 2 (IST2) compared to A7 agar plates for the detection of Ureaplasma urealyticum and Mycoplasma hominis in clinical samples. METHODOLOGY: From April to July 2013, endocervical or vaginal samples were collected from sexually active women with abnormal vaginal discharge. Each specimen was tested in parallel using the three commercial kits and the A7 agar plates. RESULTS: A total of 303 samples were included in this study, 35.6% (108/303) of which were positive on A7 plates. Sensitivities for the detection of U. urealyticum of IES, REV and IST2 were 100%, 96.2% and 95.3%, respectively while those for M. hominis were of 92.8%, 92.8% and 85.7%, respectively. Specificity was 100% for the 3 methods. Concerning antimicrobial susceptibility testing, full agreement between IES and REV was documented. CONCLUSIONS: The Mycoplasma IES kit was found to be equivalent or superior compared to other commercial culture-based assays for a rapid and accurate identification of U. urealyticum and M. hominis and detection of resistance. It might be considered a cost-effective tool for detection of these organisms, particularly attractive in developing countries.
INTRODUCTION: Culture is regarded as the gold standard for the detection of genital mycoplasma in clinical samples. Commercially available diagnostic kits, based on liquid broth cultures, provide interesting alternatives to conventional culture. We assessed the laboratory performances of Mycoplasma IES (IES), the Mycofast Revolution (REV) and Mycoplasma IST 2 (IST2) compared to A7 agar plates for the detection of Ureaplasma urealyticum and Mycoplasma hominis in clinical samples. METHODOLOGY: From April to July 2013, endocervical or vaginal samples were collected from sexually active women with abnormal vaginal discharge. Each specimen was tested in parallel using the three commercial kits and the A7 agar plates. RESULTS: A total of 303 samples were included in this study, 35.6% (108/303) of which were positive on A7 plates. Sensitivities for the detection of U. urealyticum of IES, REV and IST2 were 100%, 96.2% and 95.3%, respectively while those for M. hominis were of 92.8%, 92.8% and 85.7%, respectively. Specificity was 100% for the 3 methods. Concerning antimicrobial susceptibility testing, full agreement between IES and REV was documented. CONCLUSIONS: The Mycoplasma IES kit was found to be equivalent or superior compared to other commercial culture-based assays for a rapid and accurate identification of U. urealyticum and M. hominis and detection of resistance. It might be considered a cost-effective tool for detection of these organisms, particularly attractive in developing countries.
Authors: Eui Jeong Noh; Dong Jae Kim; Jun Young Lee; Jong Hwan Park; Jong-Seok Kim; Jae Won Han; Byoung Chan Kim; Chul Jung Kim; Sung Ki Lee Journal: Front Immunol Date: 2019-10-04 Impact factor: 7.561
Authors: Brenda Maldonado-Arriaga; Noé Escobar-Escamilla; Juan Carlos Pérez-Razo; Sofia Lizeth Alcaráz-Estrada; Ignacio Flores-Sánchez; Daniel Moreno-García; Rebeca Pérez-Cabeza de Vaca; Paul Mondragón-Terán; Jonathan Shaw; Cecilia Hernandez-Cortez; Graciela Castro-Escarpulli; Juan Antonio Suárez-Cuenca Journal: J Int Med Res Date: 2019-02-28 Impact factor: 1.671
Authors: Marinjho Emely Jonduo; Lisa Michelle Vallely; Handan Wand; Emma Louise Sweeney; Dianne Egli-Gany; John Kaldor; Andrew John Vallely; Nicola Low Journal: BMJ Open Date: 2022-08-26 Impact factor: 3.006
Authors: Francesca Gallini; Domenico Umberto De Rose; Maria Coppola; Maria Sofia Pelosi; Francesco Cota; Anthea Bottoni; Daniela Ricci; Domenico Marco Romeo; Teresa Spanu; Luca Maggio; Eugenio Mercuri; Giovanni Vento Journal: Front Pediatr Date: 2022-08-15 Impact factor: 3.569